Article
TIGIT drives the immunosuppressive environment by downregulation of metalloproteinases…
medRxiv · 2023 · Heij, L.; Reichel, K.; de Koning, W.; Bednarsch, J.; Tan, X.; Campello Deierl, J.; Clahsen-van Groningen, M.; Al-Masri, T.; van Dam, R.; Garcia Vallejo, J.; Ulmer, F.; Lang, S.; Luedde, T.; Rocha, F.; Dahl, E.; Jonigk, D.; Kuehnel, M.; Sivakumar, S.; Neumann, U.
Key facts
| Title | TIGIT drives the immunosuppressive environment by downregulation of metalloproteinases MMP2 and MMP14 in perihilar cholangiocarcinoma. |
|---|---|
| First author | Heij, L.; Reichel, K.; de Koning, W.; Bednarsch, J.; Tan, X.; Campello Deierl, J.; Clahsen-van Groningen, M.; Al-Masri, T.; van Dam, R.; Garcia Vallejo, J.; Ulmer, F.; Lang, S.; Luedde, T.; Rocha, F.; Dahl, E.; Jonigk, D.; Kuehnel, M.; Sivakumar, S.; Neumann, U. |
| Journal | medRxiv |
| Published | Aug 15, 2023 |
| DOI | 10.1101/2023.08.14.553195 |
| Devices mentioned | 017386, K040782 |
| Product codes mentioned | JAK, NSU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1